Cargando…
Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study
INTRODUCTION: Many patients with ocular myasthenia gravis (OMG) progress to generalized disease within the first 2 years of the onset of ocular symptoms. Several retrospective studies have identified risk factors associated with generalization, however these studies included patients on immunosuppre...
Autores principales: | Guo, Rong-Jing, Gao, Ting, Ruan, Zhe, Zhou, Hong-Yu, Gao, Feng, Xu, Quan, Yu, Li-Ping, Wu, Song-Di, Lei, Tao, Li, Huan-Huan, Sun, Chao, Zhang, Min, Gao, Yan-Wu, Lu, Xiao-Dan, Tang, Yong-Lan, Tang, Bao-Li, Huo, Fei-Yan, Zhu, Ying, Li, Zhu-Yi, Chang, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857387/ https://www.ncbi.nlm.nih.gov/pubmed/34729706 http://dx.doi.org/10.1007/s40120-021-00292-x |
Ejemplares similares
-
Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis
por: Ruan, Zhe, et al.
Publicado: (2022) -
COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series
por: Ruan, Zhe, et al.
Publicado: (2021) -
Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis
por: Su, Yue, et al.
Publicado: (2022) -
Do early prednisolone and other immunosuppressant therapies prevent
generalization in ocular myasthenia gravis in Western populations: a systematic
review and meta-analysis
por: Li, Mingxia, et al.
Publicado: (2019) -
Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011)